Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Achondroplasia D000130 1 associated lipids
Acinetobacter Infections D000151 4 associated lipids
Acne Vulgaris D000152 35 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Amebiasis D000562 2 associated lipids
Anaphylaxis D000707 35 associated lipids
Anaplasmataceae Infections D000711 3 associated lipids
Angina, Unstable D000789 14 associated lipids
Aphasia, Broca D001039 1 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Bacterial Infections D001424 21 associated lipids
Bartonella Infections D001474 3 associated lipids
Birth Weight D001724 23 associated lipids
Bites, Human D001734 2 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Burns D002056 34 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cat Diseases D002371 12 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Uterine Cervicitis D002575 3 associated lipids
Chancroid D002602 4 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chlamydiaceae Infections D002694 2 associated lipids
Chronic Disease D002908 7 associated lipids
Ciliary Motility Disorders D002925 2 associated lipids
Colitis D003092 69 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Conjunctivitis, Inclusion D003235 4 associated lipids
Corneal Opacity D003318 3 associated lipids
Coronary Disease D003327 70 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Crohn Disease D003424 12 associated lipids
Cross Infection D003428 9 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Sommer A Systemic antibiotics for communitywide trachoma control. 2005 Arch. Ophthalmol. pmid:15883291
Tabbara KF et al. Ocular levels of azithromycin. 1998 Arch. Ophthalmol. pmid:9869792
Miyagawa T et al. Azithromycin recovers reductions in barrier function in human gingival epithelial cells stimulated with tumor necrosis factor-α. 2016 Arch. Oral Biol. pmid:26655749
Pawlowski KS et al. Ototoxicity of topical azithromycin solutions in the guinea pig. 2010 Arch. Otolaryngol. Head Neck Surg. pmid:20479380
Brook I and Hausfeld JN Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis. 2006 Arch. Otolaryngol. Head Neck Surg. pmid:16618915
Chan KH et al. Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model. 1988 Arch. Otolaryngol. Head Neck Surg. pmid:2844210
Wu ML et al. Enterocolonic Mycobacterium avium-intracellulare. 2002 Arch. Pathol. Lab. Med. pmid:11860323
Fadlallah A et al. Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis. 2012 May-Jun Arq Bras Oftalmol pmid:22872200
Frota LC et al. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial. 2005 Apr-Jun Arq Gastroenterol pmid:16127567
Assmann G et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. 2009 Arthritis Res. Ther. pmid:19772564
St Clair EW et al. The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. 2001 Arthritis Rheum. pmid:11357896
Carter JD et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. 2010 Arthritis Rheum. pmid:20155838
Jiang B et al. Quantification of azithromycin in human plasma by liquid chromatography tandem mass spectrometry: application to a bioequivalence study. 2012 Arzneimittelforschung pmid:22344571
Wildfeuer A and Haberreiter A Intracellular activity of azithromycin against Mycobacterium avium complex in human macrophages. 1997 Arzneimittelforschung pmid:9272246
Sultana TA et al. Comparative pharmacokinetic and relative bioavailability study of coated and uncoated azithromycin powder for suspension in healthy Bangladeshi male volunteers. 2011 Arzneimittelforschung pmid:22164968
Koytchev R et al. Assessment of the bioequivalence of different formulations containing azithromycin (tablets and suspension). 2004 Arzneimittelforschung pmid:15497663
Setiawati E et al. Bioequivalence study of two azithromycin formulations in healthy subjects. 2009 Arzneimittelforschung pmid:19856795
Afghani T et al. Preventing Long-Term Ocular Complications of Trachoma With Topical Azithromycin: A 3-Year Follow-up Study. 2017 Jan-Feb Asia Pac J Ophthalmol (Phila) pmid:28161923
Magri V et al. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. 2011 Asian J. Androl. pmid:21765442
Karanth SS et al. A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual. 2012 Asian Pac J Trop Biomed pmid:23569891
Jirapongsananuruk O et al. Recurrent Campylobacter lari bacteremia in X-linked agammaglobulinemia: a case report and review. 2006 Jun-Sep Asian Pac. J. Allergy Immunol. pmid:17136884
Llor Vilà C [I'd rather give azithromycin for three days. That way the patient complies]. 2003 Aten Primaria pmid:12735886
Schriever C et al. Red wine, resveratrol, Chlamydia pneumoniae and the French connection. 2003 Atherosclerosis pmid:14644410
Hotomi M et al. Nontypeable Haemophilus influenzae isolated from intractable acute otitis media internalized into cultured human epithelial cells. 2010 Auris Nasus Larynx pmid:19505782
Shimizu T and Suzaki H Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan. 2016 Auris Nasus Larynx pmid:26441370
Hirsch R Periodontal healing and bone regeneration in response to azithromycin. 2010 Aust Dent J pmid:20604763
O'Rourke VJ Azithromycin as an adjunct to non-surgical periodontal therapy: a systematic review. 2017 Aust Dent J pmid:27492140
Higgins TJ Azithromycin. 2010 Aust Dent J pmid:21133950
Saleh A et al. Comparison of adjunctive azithromycin and amoxicillin/metronidazole for patients with chronic periodontitis: preliminary randomized control trial. 2016 Aust Dent J pmid:26836781
Fujise O et al. Regenerative effect of azithromycin on periodontitis with different levels of gingival inflammation: three case reports. 2014 Aust Dent J pmid:24861402
Pradeep AR et al. Local drug delivery of 0.5% azithromycin in the treatment of chronic periodontitis among smokers. 2013 Aust Dent J pmid:23441790
Gomi K et al. Full-mouth scaling and root planing combined with azithromycin to treat peri-implantitis. 2015 Aust Dent J pmid:25439282
Bowden FJ and Skov SJ Treating donovanosis. 1999 Aust Fam Physician pmid:10615749
Heal C et al. Genital Chlamydia trachomatis infection - a study of general practice management in northern Queensland. 2012 Aust Fam Physician pmid:22762073
Pereira A et al. Acute onset of widespread pustular eruption. 2015 Aust Fam Physician pmid:26209988
Redmond AM et al. Epidemic syphilis exhibits diverse manifestations. 2007 Aust Fam Physician pmid:17885710
SendaÄŸ F et al. Single dose oral azithromycin versus seven day doxycycline in the treatment of non-gonococcal mucopurulent endocervicitis. 2000 Aust N Z J Obstet Gynaecol pmid:10870778
van der Griend B et al. An uncommon cause of a destructive vulval lesion. 2001 Aust N Z J Obstet Gynaecol pmid:11787928
Tsubouchi K et al. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4. 2017 Autophagy pmid:28613983
Luo H et al. Identification of ribosomal RNA methyltransferase gene ermF in Riemerella anatipestifer. 2015 Avian Pathol. pmid:25690020
Juricic D et al. Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man. 2010 Basic Clin. Pharmacol. Toxicol. pmid:19906050
Srivastava P et al. Azithromycin treatment modulates cytokine production in Chlamydia trachomatis infected women. 2009 Basic Clin. Pharmacol. Toxicol. pmid:19389045
Mary N and Mahmood TA Preventing infective complications relating to induced abortion. 2010 Best Pract Res Clin Obstet Gynaecol pmid:20542471
Legrand T et al. An optimal LC-MS/MS method for determination of azithromycin in white blood cells: application to pediatric samples. 2014 Bioanalysis pmid:25383741
Cigana C et al. Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. 2006 Biochem. Biophys. Res. Commun. pmid:17045242
Berquand A et al. Real-time imaging of drug-membrane interactions by atomic force microscopy. 2004 Biochim. Biophys. Acta pmid:15328052
Fa N et al. Decrease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic, azithromycin. 2007 Biochim. Biophys. Acta pmid:17537401
Kitsiouli E et al. Effect of azithromycin on the LPS-induced production and secretion of phospholipase A2 in lung cells. 2015 Biochim. Biophys. Acta pmid:25791017
Wu Y et al. Studies on electrochemical oxidation of azithromycin and its interaction with bovine serum albumin. 2004 Bioelectrochemistry pmid:15219252
Saini H et al. Antimicrobial and antifouling efficacy of urinary catheters impregnated with a combination of macrolide and fluoroquinolone antibiotics against Pseudomonas aeruginosa. 2016 Biofouling pmid:26982572